Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orthonics was a medical technology company focused on developing innovative treatments for spinal disorders. The company's primary focus was the development of the NUBAC Disc Arthroplasty System, a synthetic protein-based hydrogel designed for nucleus pulposus replacement. This technology aimed to treat degenerative disc disease by restoring disc height and function through a minimally invasive procedure. Orthonics was acquired by Pioneer Surgical Technology in 2009 to bolster their spine portfolio and integrate advanced biomaterials into their surgical offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orthonics.